ALPHAHELIX MOL.DIAGN. SK1 (F:4MB) — Stock Price
ALPHAHELIX MOL.DIAGN. SK1 (F:4MB) is currently trading at €0.01 EUR, down 8.70% today. Over the past 52 weeks, shares have ranged between €0.01 and €0.03. This page tracks ALPHAHELIX MOL.DIAGN. SK1's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 4MB company net worth.
ALPHAHELIX MOL.DIAGN. SK1 (4MB) Stock Price Chart — Daily History & Trading Volume
The chart below tracks ALPHAHELIX MOL.DIAGN. SK1's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
ALPHAHELIX MOL.DIAGN. SK1 Income Statement — Revenue, Profit & Earnings by Year
ALPHAHELIX MOL.DIAGN. SK1's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €32.36 Million | €25.10 Million | €26.10 Million | €34.33 Million |
| Cost of Revenue | €15.30 Million | €11.60 Million | €13.79 Million | €19.08 Million |
| Gross Profit | €17.06 Million | €13.49 Million | €12.31 Million | €15.25 Million |
| Research & Development | — | — | — | — |
| SG&A | — | — | — | — |
| Total Operating Expenses | €35.85 Million | €33.18 Million | €35.03 Million | €35.86 Million |
| Operating Income | €-3.49 Million | €-8.08 Million | €-8.93 Million | €-1.53 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | — | €126.46K | €11.80K | €81.88K |
| Income Before Tax | €-3.57 Million | €-8.19 Million | €-9.69 Million | €-2.41 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €-3.54 Million | €-7.87 Million | €-9.48 Million | €-2.22 Million |
ALPHAHELIX MOL.DIAGN. SK1 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes ALPHAHELIX MOL.DIAGN. SK1's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €14.05 Million | €15.37 Million | €19.09 Million | €28.80 Million |
| Total Current Assets | €12.77 Million | €11.68 Million | €13.32 Million | €20.06 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €5.53 Million | €6.09 Million | €4.43 Million | €5.73 Million |
| Inventory | €3.86 Million | €3.72 Million | €4.38 Million | €5.70 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | — | €1.14 Million | €1.94 Million | €2.74 Million |
| Total Liabilities | €13.41 Million | €11.20 Million | €8.68 Million | €8.91 Million |
| Total Current Liabilities | €12.96 Million | €10.81 Million | €8.03 Million | €7.69 Million |
| Long-term Debt | — | — | €0.00 | €300.00K |
| Net Debt | — | €334.77K | — | — |
| Total Stockholder Equity | €637.00K | €4.18 Million | €10.41 Million | €19.89 Million |
| Retained Earnings | — | €-15.33 Million | €-7.46 Million | €2.02 Million |
ALPHAHELIX MOL.DIAGN. SK1 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how ALPHAHELIX MOL.DIAGN. SK1 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €820.00K | €-4.49 Million | €-5.45 Million | €2.87 Million |
| Capital Expenditures | €0.00 | €0.00 | €42.50K | €288.09K |
| Free Cash Flow | €820.00K | €-4.49 Million | €-5.49 Million | €2.58 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | — | €2.18 Million | €2.19 Million | €2.18 Million |
| Change in Cash | €1.41 Million | €-2.55 Million | €-4.21 Million | €1.98 Million |
ALPHAHELIX MOL.DIAGN. SK1 Earnings History — EPS Actual vs. Analyst Estimates
Track ALPHAHELIX MOL.DIAGN. SK1's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 18, 2025 | — | — | — |